153 related articles for article (PubMed ID: 30085174)
1. Preoperative risk classification using neutrophil-lymphocyte ratio and hydronephrosis for upper tract urothelial carcinoma.
Kohada Y; Hayashi T; Goto K; Kobatake K; Abdi H; Honda Y; Sentani K; Inoue S; Teishima J; Awai K; Yasui W; Matsubara A
Jpn J Clin Oncol; 2018 Sep; 48(9):841-850. PubMed ID: 30085174
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of prognosis using the neutrophil-lymphocyte ratio and erythrocyte sedimentation rate in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma.
Sung HH; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
BJU Int; 2015 Apr; 115(4):587-94. PubMed ID: 24947340
[TBL] [Abstract][Full Text] [Related]
3. A multi-institutional validation of the prognostic value of the neutrophil-to-lymphocyte ratio for upper tract urothelial carcinoma treated with radical nephroureterectomy.
Tanaka N; Kikuchi E; Kanao K; Matsumoto K; Shirotake S; Miyazaki Y; Kobayashi H; Kaneko G; Hagiwara M; Ide H; Obata J; Hoshino K; Hayakawa N; Kosaka T; Hara S; Oyama M; Momma T; Nakajima Y; Jinzaki M; Oya M
Ann Surg Oncol; 2014 Nov; 21(12):4041-8. PubMed ID: 24912614
[TBL] [Abstract][Full Text] [Related]
4. Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy.
Vartolomei MD; Mathieu R; Margulis V; Karam JA; RouprĂȘt M; Lucca I; Mbeutcha A; Seitz C; Karakiewicz PI; Fajkovic H; Wood CG; Weizer AZ; Raman JD; Rioux-Leclercq N; Haitel A; Bensalah K; Rink M; Briganti A; Xylinas E; Shariat SF
World J Urol; 2017 Jan; 35(1):121-130. PubMed ID: 27209168
[TBL] [Abstract][Full Text] [Related]
5. Preoperative hydronephrosis as a predictor of postnephroureterectomy survival in patients with upper tract urothelial carcinoma: a two-center study in Japan.
Fukui T; Kanno T; Kobori G; Moroi S; Yamada H
Int J Clin Oncol; 2020 Mar; 25(3):456-463. PubMed ID: 31482240
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study.
Nakagawa T; Komemushi Y; Kawai T; Otsuka M; Miyakawa J; Uemura Y; Kanatani A; Taguchi S; Naito A; Suzuki M; Nishimatsu H; Hirano Y; Tanaka Y; Matsumoto A; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
World J Urol; 2017 Oct; 35(10):1569-1575. PubMed ID: 28397000
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of preoperative lymphocyte-related systemic inflammatory biomarkers in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: a systematic review and meta-analysis.
Shao Y; Li W; Wang D; Wu B
World J Surg Oncol; 2020 Oct; 18(1):273. PubMed ID: 33097052
[TBL] [Abstract][Full Text] [Related]
8. Preoperative neutrophil-lymphocyte ratio as an independent prognostic marker for patients with upper urinary tract urothelial carcinoma.
Azuma T; Matayoshi Y; Odani K; Sato Y; Sato Y; Nagase Y; Oshi M
Clin Genitourin Cancer; 2013 Sep; 11(3):337-41. PubMed ID: 23665132
[TBL] [Abstract][Full Text] [Related]
9. Significance of multiple preoperative laboratory abnormalities as prognostic indicators in patients with urothelial carcinoma of the upper urinary tract following radical nephroureterectomy.
Nishikawa M; Miyake H; Kurahashi T; Fujisawa M
Int J Clin Oncol; 2018 Feb; 23(1):151-157. PubMed ID: 28856495
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Role of Neutrophil-to-lymphocyte Ratio-based Markers During Pre- and Postadjuvant Chemotherapy in Patients With Advanced Urothelial Carcinoma of Upper Urinary Tract.
Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
Clin Genitourin Cancer; 2017 Aug; 15(4):e633-e643. PubMed ID: 28174011
[TBL] [Abstract][Full Text] [Related]
11. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Cha EK; Shariat SF; Kormaksson M; Novara G; Chromecki TF; Scherr DS; Lotan Y; Raman JD; Kassouf W; Zigeuner R; Remzi M; Bensalah K; Weizer A; Kikuchi E; Bolenz C; Roscigno M; Koppie TM; Ng CK; Fritsche HM; Matsumoto K; Walton TJ; Ehdaie B; Tritschler S; Fajkovic H; MartĂnez-Salamanca JI; Pycha A; Langner C; Ficarra V; Patard JJ; Montorsi F; Wood CG; Karakiewicz PI; Margulis V
Eur Urol; 2012 Apr; 61(4):818-25. PubMed ID: 22284969
[TBL] [Abstract][Full Text] [Related]
12. Effects of Variant Histology on the Oncologic Outcomes of Patients With Upper Urinary Tract Carcinoma After Radical Nephroureterectomy: A Propensity Score-Matched Analysis.
Chung HS; Hwang EC; Kim MS; Yu SH; Jung SI; Kang TW; Choi C; Choi SH; Kwon TG; Noh JH; Kim MK; Cho WJ; Kang SG; Kang SH; Cheon J; Seo IY; Chung H; Kim HS; Lee CH; Ku JY; Ha HK; Kim BH; Jeong CW; Ku JH; Kwak C; Kwon D
Clin Genitourin Cancer; 2019 Jun; 17(3):e394-e407. PubMed ID: 30782419
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Lymphovascular Invasion in Node-Negative Upper Urinary Tract Urothelial Carcinoma Patients Undergoing Radical Nephroureterectomy.
Liu W; Zhou Z; Dong D; Sun L; Zhang G
Yonsei Med J; 2019 Feb; 60(2):174-181. PubMed ID: 30666839
[TBL] [Abstract][Full Text] [Related]
14. What is the Role of the Preoperative Blood-Based Inflammation Biomarkers in the Prognosis of Upper Tract Urothelial Carcinoma With Radical Nephroureterectomy? A Single-Centre Retrospective Study.
Luo Z; Jiao B; Huang T; Zhao H; Zhang G
Technol Cancer Res Treat; 2022; 21():15330338221095667. PubMed ID: 35585719
[No Abstract] [Full Text] [Related]
15. Combination of Platelet-Lymphocyte Ratio and Monocyte-Lymphocyte Ratio as a New Promising Prognostic Factor in Upper Tract Urothelial Carcinoma With Large Tumor Sizes > 3 cm.
Jan HC; Hu CY; Yang WH; Ou CH
Clin Genitourin Cancer; 2020 Aug; 18(4):e484-e500. PubMed ID: 32199741
[TBL] [Abstract][Full Text] [Related]
16. Preoperative Risk Classification Using Neutrophil-to-Lymphocyte Ratio and Albumin for Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy.
Zhao Z; Xie S; Feng B; Zhang S; Sun Y; Guo H; Yang R
Cancer Manag Res; 2020; 12():9023-9032. PubMed ID: 33061597
[TBL] [Abstract][Full Text] [Related]
17. Effect of tumor size on recurrence-free survival of upper tract urothelial carcinoma following surgical resection.
Espiritu PN; Sverrisson EF; Sexton WJ; Pow-Sang JM; Poch MA; Dhillon J; Spiess PE
Urol Oncol; 2014 Jul; 32(5):619-24. PubMed ID: 24495448
[TBL] [Abstract][Full Text] [Related]
18. Preoperative positive voided urine cytology predicts poor clinical outcomes in patients with upper tract urothelial carcinoma undergoing nephroureterectomy.
Liu W; Wang Z; Liu S; Yao Y; Liu Y; Zhang G
BMC Cancer; 2020 Nov; 20(1):1113. PubMed ID: 33198698
[TBL] [Abstract][Full Text] [Related]
19. Validation of the Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor in a Large Cohort of Chinese Patients with Upper Tract Urothelial Carcinoma.
Cao ZP; Guan B; Zhao GZ; Fang D; Xiong GY; Li XS; Zhou LQ
Chin Med J (Engl); 2017 Sep; 130(17):2063-2068. PubMed ID: 28836549
[TBL] [Abstract][Full Text] [Related]
20. Is neutrophil-to-lymphocytes ratio a clinical relevant preoperative biomarker in upper tract urothelial carcinoma? A meta-analysis of 4385 patients.
Vartolomei MD; Kimura S; Ferro M; Vartolomei L; Foerster B; Abufaraj M; Shariat SF
World J Urol; 2018 Jul; 36(7):1019-1029. PubMed ID: 29468284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]